GHP Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
28,143
+455
+2% +$156K 0.37% 83
2026
Q1
$9.74M Buy
27,688
+834
+3% +$297K 0.4% 85
2025
Q4
$8.79M Sell
26,854
-28
-0.1% -$8.88K 0.36% 93
2025
Q3
$7.59M Sell
26,882
-613
-2% -$178K 0.32% 109
2025
Q2
$7.68M Buy
27,495
+151
+0.6% +$42.8K 0.34% 102
2025
Q1
$8.52M Buy
27,344
+858
+3% +$253K 0.41% 90
2024
Q4
$6.9M Buy
26,486
+1,572
+6% +$466K 0.32% 115
2024
Q3
$8.03M Buy
24,914
+1,005
+4% +$329K 0.37% 100
2024
Q2
$7.47M Buy
23,909
+1,730
+8% +$508K 0.37% 100
2024
Q1
$6.31M Buy
22,179
+820
+4% +$240K 0.31% 116
2023
Q4
$6.15M Buy
21,359
+711
+3% +$194K 0.33% 110
2023
Q3
$5.87M Buy
20,648
+524
+3% +$131K 0.36% 104
2023
Q2
$5.28M Buy
20,124
+1,728
+9% +$401K 0.31% 113
2023
Q1
$4.45M Buy
18,396
+950
+5% +$233K 0.28% 127
2022
Q4
$4.58M Buy
17,446
+978
+6% +$262K 0.31% 116
2022
Q3
$3.71M Buy
16,468
+773
+5% +$187K 0.28% 127
2022
Q2
$3.82M Buy
15,695
+1,244
+9% +$305K 0.28% 126
2022
Q1
$3.49M Buy
14,451
+3,558
+33% +$817K 0.23% 148
2021
Q4
$2.45M Sell
10,893
-1,051
-9% -$222K 0.17% 174
2021
Q3
$2.54M Buy
11,944
+829
+7% +$191K 0.2% 160
2021
Q2
$2.71M Sell
11,115
-1,871
-14% -$460K 0.22% 150
2021
Q1
$3.23M Buy
12,986
+1,173
+10% +$280K 0.28% 127
2020
Q4
$2.72M Buy
11,813
+1,668
+16% +$385K 0.26% 128
2020
Q3
$2.58M Buy
10,145
+1,978
+24% +$490K 0.29% 124
2020
Q2
$1.93M Sell
8,167
-506
-6% -$115K 0.24% 133
2020
Q1
$1.76M Sell
8,673
-415
-5% -$90.6K 0.26% 121
2019
Q4
$2.19M Buy
9,088
+34
+0.4% +$7.5K 0.24% 132
2019
Q3
$1.75M Sell
9,054
-1,455
-14% -$279K 0.22% 142
2019
Q2
$1.94M Buy
10,509
+385
+4% +$68.9K 0.24% 132
2019
Q1
$1.92M Buy
10,124
+65
+0.6% +$12.4K 0.25% 132
2018
Q4
$1.96M Buy
10,059
+1,086
+12% +$212K 0.29% 114
2018
Q3
$1.86M Buy
8,973
+28
+0.3% +$5.52K 0.25% 126
2018
Q2
$1.65M Sell
8,945
-189
-2% -$33.4K 0.23% 132
2018
Q1
$1.56M Buy
9,134
+129
+1% +$23.7K 0.22% 139
2017
Q4
$1.57M Buy
9,005
+382
+4% +$67.6K 0.22% 134
2017
Q3
$1.61M Buy
8,623
+489
+6% +$86.6K 0.24% 124
2017
Q2
$1.4M Buy
8,134
+760
+10% +$124K 0.22% 130
2017
Q1
$1.21M Buy
7,374
+431
+6% +$71.6K 0.21% 140
2016
Q4
$1.01M Buy
6,943
+1,000
+17% +$151K 0.19% 151
2016
Q3
$991K Buy
5,943
+1,035
+21% +$175K 0.2% 143
2016
Q2
$747K Hold
4,908
0.16% 162
2016
Q1
$736K Sell
4,908
-547
-10% -$81.3K 0.17% 162
2015
Q4
$886K Buy
5,455
+10
+0.2% +$1.57K 0.21% 131
2015
Q3
$753K Sell
5,445
-1,324
-20% -$209K 0.19% 141
2015
Q2
$1.07M Hold
6,769
0.26% 112
2015
Q1
$1.08M Hold
6,769
0.28% 99
2014
Q4
$1.08M Buy
6,769
+4,445
+191% +$693K 0.3% 92
2014
Q3
$326K Hold
2,324
0.1% 205
2014
Q2
$275K Sell
2,324
-66
-3% -$7.64K 0.08% 220
2014
Q1
$295K Buy
+2,390
New +$290K 0.09% 209

Other funds holding AMGN

GHP Investment Advisors's AMGN Position: Q2 2026 in Review

GHP Investment Advisors increased its Amgen (AMGN) stake by 1.6% in Q2 2026, buying an estimated $156K and bringing the position to 28,143 shares worth $10.2M. The position accounts for 0.37% of the portfolio, ranked #83.

GHP Investment Advisors first reported a position in AMGN in Q1 2014 and has held it in 50 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GHP Investment Advisors held 28,143 shares of Amgen worth $10.2M as of Q2 2026.
  • GHP Investment Advisors bought 455 Amgen shares in Q2 2026, an estimated $156K.
  • Amgen made up 0.37% of GHP Investment Advisors's portfolio in Q2 2026, its #83 holding.
  • GHP Investment Advisors first reported a position in Amgen in Q1 2014 and has held it in 50 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.